Cargando…

Extent of Surgery and Implications of Transection Margin Status after Resection of IPMNs

Appropriate surgical strategies for management of intraductal papillary mucinous neoplasms (IPMNs) of the pancreas are a matter of debate. Preoperative and intraoperative evaluation of malignant potential of IPMN and of patient's comorbidities is of paramount importance to balance potential com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paini, Marina, Crippa, Stefano, Scopelliti, Filippo, Baldoni, Andrea, Manzoni, Alberto, Belfiori, Giulio, Partelli, Stefano, Falconi, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167807/ https://www.ncbi.nlm.nih.gov/pubmed/25276122 http://dx.doi.org/10.1155/2014/269803

Ejemplares similares

The Role of Hyponatraemia Before Surgery in Patients With Radical Resected Pancreatic Cancer
por: Berardi, Rossana, et al.
Publicado: (2020)

Long-Term Outcome after Laparoscopic Bowel Resections for Deep Infiltrating Endometriosis: A Single-Center Experience after 900 Cases
por: Ruffo, Giacomo, et al.
Publicado: (2014)

Management of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphology
por: Crippa, Stefano, et al.
Publicado: (2016)

Prognostic impact of Ki‐67 proliferative index in resectable pancreatic ductal adenocarcinoma
por: Pergolini, I., et al.
Publicado: (2019)

Postoperative Outcomes and Functional Recovery After Preoperative Combination Chemotherapy for Pancreatic Cancer: A Propensity Score-Matched Study
por: Pecorelli, Nicolò, et al.
Publicado: (2019)

Surgery for Intraductal Papillary Mucinous Neoplasms of the Pancreas: Preoperative Factors Tipping the Scale of Decision-Making
por: Marchegiani, Giovanni, et al.
Publicado: (2022)

Surgical management of pancreatic neuroendocrine neoplasms
por: Partelli, Stefano, et al.
Publicado: (2014)

Nerves and Pancreatic Cancer: New Insights into A Dangerous Relationship
por: Gasparini, Giulia, et al.
Publicado: (2019)

Pancreatic cystic neoplasms: What is the most cost-effective follow-up strategy?
por: Maggi, Giulia, et al.
Publicado: (2018)

Long-Term Pancreatic Functional Impairment after Surgery for Neuroendocrine Neoplasms
por: Andreasi, Valentina, et al.
Publicado: (2019)

Imaging of IPMN of the pancreas: evaluation of malignant potential and resectability
por: Lee, Jeong Min
Publicado: (2015)

CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma
por: Maggino, Laura, et al.
Publicado: (2022)

Geographical Disparities and Patients’ Mobility: A Plea for Regionalization of Pancreatic Surgery in Italy
por: Balzano, Gianpaolo, et al.
Publicado: (2023)

Somatostatin analogs: is one better than other?
por: Rossana, Berardi, et al.
Publicado: (2017)

Prediction of Early Distant Recurrence in Upfront Resectable Pancreatic Adenocarcinoma: A Multidisciplinary, Machine Learning-Based Approach
por: Palumbo, Diego, et al.
Publicado: (2021)

Pancreatic fistula after pancreaticoduodenectomy—does surgical technique matter?
por: Crippa, Stefano, et al.
Publicado: (2020)

Correction: Long-term follow-up of low-risk branchduct IPMNs of the pancreas: is main pancreatic duct dilatation the most worrisome feature?
por: Petrone, Maria Chiara, et al.
Publicado: (2018)

Long-term follow-up of low-risk branch-duct IPMNs of the pancreas: is main pancreatic duct dilatation the most worrisome feature?
por: Petrone, Maria Chiara, et al.
Publicado: (2018)

State-of-the-art surgical treatment of IPMNs
por: Salvia, Roberto, et al.
Publicado: (2021)

Comparison of hyperspectral imaging and fluorescence angiography for the determination of the transection margin in colorectal resections—a comparative study
por: Jansen-Winkeln, Boris, et al.
Publicado: (2020)

Extent of Hyperostotic Bone Resection in Convexity Meningioma to Achieve Pathologically Free Margins
por: Fathalla, Hussein, et al.
Publicado: (2020)

Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms
por: Capurso, Gabriele, et al.
Publicado: (2020)

Quantitative imaging to evaluate malignant potential of IPMNs
por: Hanania, Alexander N., et al.
Publicado: (2016)

Correction to: Comparison of hyperspectral imaging and fluorescence angiography for the determination of the transection margin in colorectal resections—a comparative study
por: Jansen-Winkeln, Boris, et al.
Publicado: (2022)

Preoperative CT image analysis to improve risk stratification for clinically relevant pancreatic fistula after distal pancreatectomy
por: Pecorelli, Nicolò, et al.
Publicado: (2022)

Intraductal papillary mucinous neoplasm of the pancreas (IPMN): clinico-pathological correlations and surgical indications
por: Baiocchi, Gian Luca, et al.
Publicado: (2010)

Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression
por: Gentiluomo, Manuel, et al.
Publicado: (2023)

Evaluating IPMN and pancreatic carcinoma utilizing quantitative histopathology
por: Glazer, Evan S., et al.
Publicado: (2016)

Humoral Predictors of Malignancy in IPMN: A Review of the Literature
por: Nista, Enrico C., et al.
Publicado: (2021)

Extent of Resection in Meningioma: Predictive Factors and Clinical Implications
por: Lemée, Jean-Michel, et al.
Publicado: (2019)

Reappraisal of the Immunophenotype of Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMNs)—Gastric Pyloric and Small Intestinal Immunophenotype Expression in Gastric and Intestinal Type IPMNs—
por: Kobayashi, Mikiko, et al.
Publicado: (2014)

Endoscopic ultrasound radiofrequency ablation of pancreatic insulinoma in elderly patients: Three case reports
por: Rossi, Gemma, et al.
Publicado: (2022)

Precursor Lesions for Sporadic Pancreatic Cancer: PanIN, IPMN, and MCN
por: Distler, M., et al.
Publicado: (2014)

Characterization and management of cystic pancreatic neoplasms communicating lesions (IPMN)
por: Morana, Giovanni, et al.
Publicado: (2014)

Invasive carcinoma derived from branch duct-type IPMN may be a more aggressive neoplasm than that derived from main duct-type IPMN
por: OKABAYASHI, TAKEHIRO, et al.
Publicado: (2013)

Pancreatic ductal adenocarcinoma in 2017: Time to change the therapeutic algorithm?
por: Crippa, Stefano, et al.
Publicado: (2017)

Dual Tracer 68Ga-DOTATOC and 18F-FDG PET Improve Preoperative Evaluation of Aggressiveness in Resectable Pancreatic Neuroendocrine Neoplasms
por: Mapelli, Paola, et al.
Publicado: (2021)

CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype
por: Mattiolo, Paola, et al.
Publicado: (2020)

Pro-tumor Tfh2 cells induce detrimental IgG4 production and PGE(2)-dependent IgE inhibition in pancreatic cancer
por: De Monte, Lucia, et al.
Publicado: (2023)

Do molecular tests really differentiate malignant IPMNS from benign?
por: Basar, Omer, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_l69asdm4ukn0facstfiqggg0bs